公司资料
Better Therapeutics 股价、新闻与催化剂
- 股票代码:
- BTTX
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
0.00 USD (0.00%)
收盘价
最后更新: 2026年8月17日
—
市值
股价为何变动
Current closing-price context is not available for BTTX.
公司概览
业务概览
Better Therapeutics was a digital therapeutics company focused on behavior-change software for cardiometabolic disease. The company tried to turn prescription-grade software into a chronic-care treatment option, but its identity was always tied to the difficult economics of digital health.
所在地与行业分类
Better Therapeutics was headquartered in the United States and listed on NASDAQ. It sat in digital health rather than classic biotechnology, with a product profile centered on software-delivered care.
商业模式特征
The business depended on payer adoption, clinical validation, and the ability to show that software could meaningfully change chronic-disease outcomes. Investors watched commercialization progress, reimbursement, and platform credibility more than clinical trial binaries.
生物医药行业定位
Better Therapeutics occupied a small digital-therapeutics niche within healthcare innovation. Compared with drug developers, its valuation was more sensitive to commercial traction and payer access than to FDA-drug milestones.
未来催化剂
- Better Therapeutics is largely a legacy / closeout story now, so the catalysts are any strategic or asset-resolution update rather than a new product cycle. The market is focused on what remains after the digital-therapy unwind.
近期新闻
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。